Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

Journal of Clinical Oncology

Volumn 20, Issue 2, 2002, Pages 379-387

  Bos, Reinhard ^a   Van der Hoeven, Jacobus J M ^a   Van der Wall, Elsken ^a   Van der Groep, Petra ^a   Van Diest, Paul J ^a   Comans, Emile F I ^a   Joshi, Urvi ^a   Semenza, Gregg L ^a   Hoekstra, Otto S ^a   Lammertsma, Adriaan A ^a   Molthoff, Carla F M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER 1; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MICROCIRCULATION; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; NECROSIS; NUCLEAR PROTEINS; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED; TRANSCRIPTION FACTORS;

EID: 0037080449     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.2.379     Document Type: Article

References (54)

1. The metabolism of tumours in the body
2. Enzymology of cancer cells (first of two parts)
3. Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients
4. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
5. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1
6. Oncogenic alterations of metabolism
7. Levels of hypoxia-inducible factor-1-alpha during breast carcinogenesis
8. Inaugural article: Positron emission tomography provides molecular imaging of biological processes
9. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: An overview of different analytical methods
10. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: Use and limitations
11. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose
12. Positron emission tomography using 18F-Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
13. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: A method for early therapy evaluation?
14. Positron emission tomography using 18F-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
15. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation
16. 18F]FDG uptake in non-small cell lung cancer
17. Angiogenesis in cancer and other diseases
18. Facilitated glucose transporters in epithelial cells
19. Intracellular organization of insulin signaling and GLUT 4 translocation
20. FDG accumulation and tumor biology
21. Suppression of tumor growth through disruption of hypoxia-inducible transcription
22. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
23. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
24. Fully automated microvessel counting and hot spot selection by image processing of whole-tumour sections in invasive breast cancer
25. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer
26. Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project
27. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: Classical and random mitotic activity assessments with correction for volume percentage of epithelium
28. Transport of sugars in tumor cell membranes
29. Over-expression of facilitative glucose transporter genes in human cancer
30. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
31. GLUT-1 expression in human breast carcinoma: Correlation with known prognostic markers
32. Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis
33. Overexpression of Glut-1 glucose transporter in human breast cancer: An immunohistochemical study
34. Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between Glut-1 expression and FDG uptake
35. Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species
36. Fluorodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo - Comparison with DNA flow cytometry in head and neck tumors
37. Glucose catabolism in cancer cells: The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53
38. Aberrant glycolytic metabolism of cancer cells: A remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase
39. Mammalian hexokinases and their abnormal expression in cancer
40. Correlation of glucose consumption and tumor cell density in astrocytomas: A stereotactic PET study
41. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography
42. F-18 FDG uptake in breast infection and inflammation
43. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis
44. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: A PET study
45. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?
46. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma
47. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas
48. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia
49. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: A microautoradiographic study
50. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma
51. Overexpression of hypoxia-inducible factor 1-alpha in common human cancers and their metastases
52. Regulation of glut1 mRNA by hypoxia-inducible factor-1: Interaction between H-ras and hypoxia
53. Large-core biopsy guns: Comparison for yield of breast tissue
54. Percutaneous large-core breast biopsy: A multi-institutional study